$KALA
KALA BIO, Inc.

2021 Q1 Form 10-Q Financial Statement

#000155837021005904 Filed on May 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $3.266M $1.071M
YoY Change 204.95% -22.73%
Cost Of Revenue $760.0K $350.0K
YoY Change 117.14% 45.83%
Gross Profit $2.510M $720.0K
YoY Change 248.61% -37.39%
Gross Profit Margin 76.85% 67.23%
Selling, General & Admin $27.70M $15.41M
YoY Change 79.77% -15.53%
% of Gross Profit 1103.55% 2140.0%
Research & Development $3.126M $5.434M
YoY Change -42.47% -21.93%
% of Gross Profit 124.54% 754.72%
Depreciation & Amortization $248.0K $230.0K
YoY Change 7.83% 35.29%
% of Gross Profit 9.88% 31.94%
Operating Expenses $31.58M $21.20M
YoY Change 48.99% -16.67%
Operating Profit -$28.31M -$20.13M
YoY Change 40.69% -17.13%
Interest Expense $2.141M $2.128M
YoY Change 0.61% -258.81%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$30.41M -$21.96M
YoY Change 38.48% -13.51%
Income Tax
% Of Pretax Income
Net Earnings -$30.41M -$21.96M
YoY Change 38.52% -13.53%
Net Earnings / Revenue -931.17% -2049.95%
Basic Earnings Per Share -$0.49
Diluted Earnings Per Share -$0.49 -$538.8K
COMMON SHARES
Basic Shares Outstanding 61.66M
Diluted Shares Outstanding 61.66M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $156.0M $196.5M
YoY Change -20.61% 41.47%
Cash & Equivalents $128.0M $196.5M
Short-Term Investments $28.00M
Other Short-Term Assets $2.600M $3.700M
YoY Change -29.73% 164.29%
Inventory $8.241M $5.300M
Prepaid Expenses
Receivables $12.21M $4.800M
Other Receivables $0.00 $0.00
Total Short-Term Assets $179.1M $210.2M
YoY Change -14.81% 39.76%
LONG-TERM ASSETS
Property, Plant & Equipment $3.042M $31.90M
YoY Change -90.46% -6.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $19.20M $16.40M
YoY Change 17.07% 30.16%
Total Long-Term Assets $50.76M $48.30M
YoY Change 5.1% 3.65%
TOTAL ASSETS
Total Short-Term Assets $179.1M $210.2M
Total Long-Term Assets $50.76M $48.30M
Total Assets $229.8M $258.5M
YoY Change -11.09% 31.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.855M $1.200M
YoY Change 137.92% -53.85%
Accrued Expenses $15.15M $16.10M
YoY Change -5.91% 34.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $19.99M $17.30M
YoY Change 15.54% 18.49%
LONG-TERM LIABILITIES
Long-Term Debt $72.52M $71.40M
YoY Change 1.57% 1.28%
Other Long-Term Liabilities $27.50M $28.30M
YoY Change -2.83% -4.39%
Total Long-Term Liabilities $100.0M $99.70M
YoY Change 0.35% -0.4%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.99M $17.30M
Total Long-Term Liabilities $100.0M $99.70M
Total Liabilities $120.0M $117.0M
YoY Change 2.59% 2.09%
SHAREHOLDERS EQUITY
Retained Earnings -$430.2M
YoY Change
Common Stock $64.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $109.8M $141.5M
YoY Change
Total Liabilities & Shareholders Equity $229.8M $258.5M
YoY Change -11.09% 31.22%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$30.41M -$21.96M
YoY Change 38.52% -13.53%
Depreciation, Depletion And Amortization $248.0K $230.0K
YoY Change 7.83% 35.29%
Cash From Operating Activities -$32.64M -$19.88M
YoY Change 64.19% -36.22%
INVESTING ACTIVITIES
Capital Expenditures -$220.0K -$290.0K
YoY Change -24.14% -34.09%
Acquisitions
YoY Change
Other Investing Activities $48.25M
YoY Change
Cash From Investing Activities $48.03M -$292.0K
YoY Change -16548.97% -33.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $34.71M $130.8M
YoY Change -73.45%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 35.32M 131.2M
YoY Change -73.08% 437170.0%
NET CHANGE
Cash From Operating Activities -32.64M -19.88M
Cash From Investing Activities 48.03M -292.0K
Cash From Financing Activities 35.32M 131.2M
Net Change In Cash 50.71M 111.0M
YoY Change -54.32% -451.52%
FREE CASH FLOW
Cash From Operating Activities -$32.64M -$19.88M
Capital Expenditures -$220.0K -$290.0K
Free Cash Flow -$32.42M -$19.59M
YoY Change 65.49% -36.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
490 Arsenal Way, Suite 120
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown
CY2021Q1 dei Entity File Number
EntityFileNumber
001-38150
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
KALA PHARMACEUTICALS, INC.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-0604595
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001479419
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021Q1 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2021Q1 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63805108
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58915375
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
CY2021Q1 dei City Area Code
CityAreaCode
781
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
996-5252
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2021Q1 dei Trading Symbol
TradingSymbol
KALA
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
64642365
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
127970000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
77264000
CY2021Q1 us-gaap Short Term Investments
ShortTermInvestments
28015000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
76276000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12206000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9604000
CY2021Q1 us-gaap Inventory Net
InventoryNet
8241000
CY2020Q4 us-gaap Inventory Net
InventoryNet
5229000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2633000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3006000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
179065000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
171379000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3042000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3166000
CY2021Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
6200000
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
6219000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28542000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27853000
CY2021Q1 kala Restricted Cash And Other Assets Noncurrent
RestrictedCashAndOtherAssetsNoncurrent
12978000
CY2020Q4 kala Restricted Cash And Other Assets Noncurrent
RestrictedCashAndOtherAssetsNoncurrent
12989000
CY2021Q1 us-gaap Assets
Assets
229827000
CY2020Q4 us-gaap Assets
Assets
221606000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2855000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1724000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15149000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18971000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1985000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1530000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
19989000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22225000
CY2021Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
27525000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
27143000
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
72521000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
72243000
CY2021Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
100046000
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
99386000
CY2021Q1 us-gaap Liabilities
Liabilities
120035000
CY2020Q4 us-gaap Liabilities
Liabilities
121611000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63805108
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58915375
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
64000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
59000
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
539920000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
499715000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-430195000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-399783000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
109792000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
99995000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
229827000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
221606000
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3266000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1071000
CY2021Q1 kala Product Revenue Cost
ProductRevenueCost
755000
CY2020Q1 kala Product Revenue Cost
ProductRevenueCost
354000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
27699000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15408000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3126000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5434000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
31580000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
21196000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-28314000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-20125000
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
43000
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
298000
CY2021Q1 us-gaap Interest Expense
InterestExpense
2141000
CY2020Q1 us-gaap Interest Expense
InterestExpense
2128000
CY2021Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2098000
CY2020Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1830000
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30412000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21955000
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.49
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.54
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
61655867
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40761984
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-30412000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21955000
CY2021Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30413000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21955000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
99995000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
184000
CY2021Q1 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
991000
CY2021Q1 kala Stock Issued During Period Value New Issues At Market
StockIssuedDuringPeriodValueNewIssuesAtMarket
34709000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
431000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4886000
CY2021Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-30412000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
109792000
CY2021Q1 kala Non Cash Operating Lease
NonCashOperatingLease
529000
CY2020Q1 kala Non Cash Operating Lease
NonCashOperatingLease
473000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
29692000
CY2020Q1 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
388000
CY2020Q1 kala Stock Issued During Period Value New Issues At Market
StockIssuedDuringPeriodValueNewIssuesAtMarket
12546000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
167000
CY2020Q1 us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
8011000
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
118207000
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
269000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2584000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-21955000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
141510000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-30412000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-21955000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
248000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
230000
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
278000
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
253000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4702000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2497000
CY2021Q1 kala Amortization Of Discount On Available For Sale Securities
AmortizationOfDiscountOnAvailableForSaleSecurities
10000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2602000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6769000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-373000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-99000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2809000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
579000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1237000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1332000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3822000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6023000
CY2021Q1 kala Increase Decrease In Lease And Other Liabilities Noncurrent
IncreaseDecreaseInLeaseAndOtherLiabilitiesNoncurrent
-372000
CY2020Q1 kala Increase Decrease In Lease And Other Liabilities Noncurrent
IncreaseDecreaseInLeaseAndOtherLiabilitiesNoncurrent
-312000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32640000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19880000
CY2021Q1 kala Payments To Acquire Property Plant And Equipment And Other Assets
PaymentsToAcquirePropertyPlantAndEquipmentAndOtherAssets
219000
CY2020Q1 kala Payments To Acquire Property Plant And Equipment And Other Assets
PaymentsToAcquirePropertyPlantAndEquipmentAndOtherAssets
292000
CY2021Q1 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
48250000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
48031000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-292000
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
34709000
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
130754000
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
9000
CY2020Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
8000
CY2021Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
615000
CY2020Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
435000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
35315000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
131181000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
50706000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
111009000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
89756000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
98031000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
140462000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
209040000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
140462000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
209040000
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
12492000
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
12584000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
127970000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
196456000
CY2021Q1 kala Capital Expenditures Incurred But Not Yet Paid Accounts Payable
CapitalExpendituresIncurredButNotYetPaidAccountsPayable
24000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
1851000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
1875000
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1218000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-430195000
CY2021Q1 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
28012000
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3000
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
28015000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
76272000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
76276000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2021Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
995000
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
801000
CY2021Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
9303000
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
6437000
CY2021Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4143000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4210000
CY2021Q1 kala Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
14441000
CY2020Q4 kala Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
11448000
CY2021Q1 us-gaap Inventory Net
InventoryNet
8241000
CY2021Q1 us-gaap Inventory Noncurrent
InventoryNoncurrent
6200000
CY2020Q4 us-gaap Inventory Net
InventoryNet
5229000
CY2020Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
6219000
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5550000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9676000
CY2021Q1 kala Accrued Revenue Reserves
AccruedRevenueReserves
6345000
CY2020Q4 kala Accrued Revenue Reserves
AccruedRevenueReserves
5224000
CY2021Q1 kala Accrued Commercialization Cost
AccruedCommercializationCost
949000
CY2020Q4 kala Accrued Commercialization Cost
AccruedCommercializationCost
2103000
CY2021Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
750000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
926000
CY2021Q1 kala Accrued Contract Manufacturing
AccruedContractManufacturing
826000
CY2020Q4 kala Accrued Contract Manufacturing
AccruedContractManufacturing
336000
CY2021Q1 kala Development Costs Current
DevelopmentCostsCurrent
206000
CY2020Q4 kala Development Costs Current
DevelopmentCostsCurrent
154000
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
523000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
552000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15149000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
18971000
CY2019Q4 kala Number Of Vehicles Leased
NumberOfVehiclesLeased
65
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
450000
CY2019 kala Vehicles Leased Term
VehiclesLeasedTerm
P3Y
CY2021Q1 kala Number Of Additional Vehicles Leased
NumberOfAdditionalVehiclesLeased
54
CY2021Q1 kala Vehicles Leased Term
VehiclesLeasedTerm
P3Y
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1216000
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1185000
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
509000
CY2020Q1 us-gaap Variable Lease Cost
VariableLeaseCost
410000
CY2021Q1 us-gaap Lease Cost
LeaseCost
1725000
CY2020Q1 us-gaap Lease Cost
LeaseCost
1595000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1584000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1444000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1512964
CY2021Q1 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P10Y1M6D
CY2020Q4 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P10Y3M18D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.096
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.098
CY2021Q1 kala Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
248505
CY2020 kala Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
248505
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.730
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.737
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0050
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0107
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.42
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1365592
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4702000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2497000
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2021Q1 kala Purchase Obligations Fiscal Year Maturity Schedule Table Textblock
PurchaseObligationsFiscalYearMaturityScheduleTableTextblock
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;line-height:1.19;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:84.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:84.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Years Ending December 31,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">2021 (remaining nine months)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;">2,295 </p></td></tr><tr><td style="vertical-align:bottom;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">2022</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;">5,390 </p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">2023</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;"> 6,285</p></td></tr><tr><td style="vertical-align:bottom;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;"> 7,875</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">2025</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;"> 8,199</p></td></tr><tr><td style="vertical-align:bottom;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Thereafter</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;"> 17,925</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:84.38%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">Total minimum purchase commitments</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:1.67%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;margin:0pt;">$</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:11.26%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;">47,969 </p></td></tr></table>
CY2021Q1 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
2295000
CY2021Q1 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
5390000
CY2021Q1 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
6285000
CY2021Q1 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
7875000
CY2021Q1 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
8199000
CY2021Q1 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
17925000
CY2021Q1 us-gaap Contractual Obligation
ContractualObligation
47969000

Files In Submission

Name View Source Status
0001558370-21-005904-index-headers.html Edgar Link pending
0001558370-21-005904-index.html Edgar Link pending
0001558370-21-005904.txt Edgar Link pending
0001558370-21-005904-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
kala-20210331.xsd Edgar Link pending
kala-20210331x10q.htm Edgar Link pending
kala-20210331x10q_htm.xml Edgar Link completed
kala-20210331xex31d1.htm Edgar Link pending
kala-20210331xex31d2.htm Edgar Link pending
kala-20210331xex32d1.htm Edgar Link pending
kala-20210331xex32d2.htm Edgar Link pending
kala-20210331_cal.xml Edgar Link unprocessable
kala-20210331_def.xml Edgar Link unprocessable
kala-20210331_lab.xml Edgar Link unprocessable
kala-20210331_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending